Position in BEAM
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$55,410,944
+$42,698,998 QoQ
Shares Held
1,614,538
+202.7% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
2.55%
of 13F equity value
Holder Rank
#16
of 274 holders
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BEAM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Contrarius Group Holdings Ltd holds $88,493,401 across 2 Biotechnology names. BEAM ranks #1 (62.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
This page
|
1,614,538 | $55,410,944 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
1,955,228 | $33,082,457 |
All Filings in BEAM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $55,410,944 | 1,614,538 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $12,711,946 | 533,443 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $37,212,438 | 1,533,269 | Shares | Defined | 2025-11-12 | |
| 2025-03-31 | $2,469,959 | 126,470 | Shares | Defined | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||